Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MDGL | NBIX | SMMT | ||
| Company | Madrigal Pharmaceuticals Inc | Neurocrine Bioscienc | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 534.50 | 174.77 | 13.67 | ||
| High | 548.53 | 178.94 | 14.60 | ||
| Low | 534.50 | 174.10 | 13.63 | ||
| Latest | 546.15 | 178.69 | 14.59 | ||
| Change | +10.46 | +5.69 | +1.09 | ||
| % Change | +1.95% | +3.29% | +8.07% | ||
| Volume | 107,060 | 842,053 | 2,681,829 | ||
| 20-Day Average Volume | 423,158 | 1,110,496 | 3,960,132 | ||
| Previous Close | 535.69 | 173.00 | 13.50 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 534.52 | 171.98 | 14.75 | ||
| 20-Day Raw Stochastic | 60.84% | 83.77% | 39.96% | ||
| 20-Day Relative Strength | 55.24 | 63.68 | 45.38 | ||
| Weighted Alpha | +64.33 | +41.88 | -40.92 | ||
| Today's Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 8% Buy | 72% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.37% since 07/14/26 | +3.35% since 07/14/26 | -6.69% since 07/14/26 | ||
| Low | 529.63 on 07/15/26 | 169.01 on 07/16/26 | 13.36 on 07/17/26 | ||
| High | 560.09 on 07/17/26 | 178.94 on 07/21/26 | 15.62 on 07/15/26 | ||
| 1-Month | |||||
| %Chg | +7.61% since 06/18/26 | +12.33% since 06/18/26 | +4.98% since 06/18/26 | ||
| Low | 500.80 on 06/22/26 | 159.32 on 06/22/26 | 13.36 on 07/17/26 | ||
| High | 569.44 on 07/09/26 | 181.18 on 07/10/26 | 16.05 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +3.13% since 04/21/26 | +36.55% since 04/21/26 | -45.28% since 04/21/26 | ||
| Low | 445.20 on 06/03/26 | 126.49 on 04/29/26 | 12.55 on 06/10/26 | ||
| High | 569.44 on 07/09/26 | 181.18 on 07/10/26 | 26.77 on 04/22/26 | ||
| 6-Month | |||||
| %Chg | +9.51% since 01/21/26 | +31.31% since 01/21/26 | -14.33% since 01/21/26 | ||
| Low | 416.21 on 03/03/26 | 122.14 on 02/12/26 | 12.55 on 06/10/26 | ||
| High | 572.20 on 03/26/26 | 181.18 on 07/10/26 | 29.23 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,350,864 | 17,395,150 | 10,478,201 | ||
| Shares Outstanding, K | 23,056 | 100,550 | 776,163 | ||
| Annual Sales | 958,400,000 | 2,860,500,000 | 0 | ||
| Annual Net Income | -288,280,000 | 478,600,000 | -1,079,590,000 | ||
| Last Quarter Sales | 311,340,000 | 814,500,000 | 0 | ||
| Last Quarter Net Income | -94,390,000 | 197,900,000 | -189,420,000 | ||
| 60-Month Beta | -1.05 | 0.39 | -1.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.25 on 05/06/26 | 1.94 on 05/05/26 | -0.24 on 04/30/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 07/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.77 | 0.00 | ||